 "Orchid Pharma net loss widens")
Orchid Pharma has posted a net loss of Rs 166.27 crore during the quarter ended June 30, 2016, as compared to a net loss of Rs 47.56 crore registered in the same period of last financial year.
The total income from operations stood at Rs 190.91 crore during the quarter, as against Rs 256.33 crore during the same quarter last year.
"The reduced turnover is on account of product mix and capacity utilisation," said K Raghavendra Rao, managing director, Orchid Pharma. However, the proposed launch of new products during the current financial year, the company is confident of improving the volumes and profitability in the ensuing quarter, he added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app